---
category: news
title: "Experimental Alzheimer’s Drug Slows Cognitive Decline in Large Study"
excerpt: "The experimental Alzheimer’s disease drug lecanemab slowed the progression of cognitive decline by 27 percent in a large, late-stage clinical trial, the drugmakers Biogen and Eisai said."
publishedDateTime: 2022-10-05T00:11:00Z
originalUrl: "https://www.everydayhealth.com/alzheimers-disease/experimental-alzheimers-drug-slows-cognitive-decline-in-large-study/"
webUrl: "https://www.everydayhealth.com/alzheimers-disease/experimental-alzheimers-drug-slows-cognitive-decline-in-large-study/"
type: article

provider:
  name: Everyday Health
  domain: everydayhealth.com

topics:
  - Microsoft AI
  - AI

secured: "JF20z9EFWuRye+InRtWXhS0CzunhJ/QaSEoxV7XUFktKusjVjIWxE6VgUTx509B7T2zNsiAo9ePnb9QuxWYWR0pxSu63hON1n/lRWd1jKcnSXzRr5L+6gJ11RnUt8jl0XB6ZXkAbvNtFjM+dT3utyepoI6ukvotNa26YfBZFgIquRuDc7NOWD654ll56vyMPyfn06xxZnfolMPkGKJn/4sVQfu/pYtNkxj424NBfnjYHKIfdJ1ZS1hPW7jzQileTQfpXI1IgmLMosWKnAg6YrFhpkfr9m48N8TGrz0d1/6jaroPWJzEus44ST3jEVD+QpELML/u+5oKZqTn5mwmGhIniJ9WSwpkgdGlyq0nN0j0=;hCGJFUfx8kOP0qSTAO1WVg=="
---

